Stockscreener 앱 받기
13.10
1.13%
-0.15
시간 외 거래:
13.00
-0.10
-0.76%
전일 마감가:
$13.25
열려 있는:
$13.23
하루 거래량:
381.13K
Relative Volume:
0.59
시가총액:
$715.22M
수익:
$8.78M
순이익/손실:
$-104.70M
주가수익비율:
-5.5274
EPS:
-2.37
순현금흐름:
$-82.68M
1주 성능:
+1.47%
1개월 성능:
+9.08%
6개월 성능:
+15.42%
1년 성능:
-7.36%
1일 변동 폭
$12.88
$13.48
1주일 범위
$12.71
$13.48
52주 변동 폭
$5.35
$16.15
Stoke Therapeutics Inc Stock (STOK) Company Profile
명칭
Stoke Therapeutics Inc
전화
781-430-8200
주소
45 WIGGINS AVENUE, BEDFORD, MA
STOK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STOK
Stoke Therapeutics Inc
|
13.10 | 719.04M | 8.78M | -104.70M | -82.68M | -2.37 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Stoke Therapeutics Inc Stock (STOK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-18 | 개시 | Jefferies | Buy |
| 2024-12-20 | 개시 | Chardan Capital Markets | Buy |
| 2024-10-14 | 재개 | Leerink Partners | Outperform |
| 2024-03-26 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-11-20 | 재개 | JP Morgan | Neutral |
| 2023-07-25 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-05-01 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-04-26 | 재개 | Canaccord Genuity | Buy |
| 2023-01-06 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2022-10-24 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-01-31 | 개시 | Jefferies | Buy |
| 2021-12-03 | 개시 | BofA Securities | Buy |
| 2021-11-22 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-05-18 | 개시 | UBS | Neutral |
| 2021-05-10 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-02-10 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2020-12-15 | 재개 | H.C. Wainwright | Buy |
| 2020-12-11 | 재확인 | Needham | Buy |
| 2020-10-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-09-29 | 재개 | JP Morgan | Neutral |
| 2020-09-29 | 개시 | Needham | Buy |
| 2019-12-18 | 개시 | Wedbush | Outperform |
| 2019-11-12 | 개시 | BTIG Research | Buy |
| 2019-10-25 | 개시 | H.C. Wainwright | Buy |
| 2019-07-15 | 개시 | Canaccord Genuity | Buy |
| 2019-07-15 | 개시 | Cowen | Outperform |
| 2019-07-15 | 개시 | Credit Suisse | Outperform |
| 2019-07-15 | 개시 | JP Morgan | Overweight |
모두보기
Stoke Therapeutics Inc 주식(STOK)의 최신 뉴스
Building trade automation scripts for Stoke Therapeutics Inc.Algorithmic Forecast for Swing Trading Picks - Newser
Stoke Therapeutics STOK 2025Q2 Earnings Preview Upside Potential on Innovative Fluorescence Applications - AInvest
Stoke Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayChart Pattern Recognition for Profit Timing - Newser
Stoke Therapeutics to Host Q2 2025 Business and Financial Update Webcast and Conference Call. - AInvest
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Second Quarter 2025 Business and Financial Updates - The Globe and Mail
Stoke Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference - BioSpace
Stoke Therapeutics to Showcase Dravet Syndrome RNA Treatment at Major Growth Conference - Stock Titan
Published on: 2025-08-05 00:18:53 - beatles.ru
Combining machine learning predictions for Stoke Therapeutics Inc.Predictive Short-Term Market Reversal Alerts - Newser
Stoke Therapeutics (STOK) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Will Stoke Therapeutics Inc. bounce back from current supportFree Short Term Buy List With Stop Protection - Newser
Trendline Breach Raises Concern for Stoke Therapeutics Inc. InvestorsVerified Signal From Chart Patterns Detected - metal.it
Should I hold or sell Stoke Therapeutics Inc. stock in 2025Maximize returns with strategic portfolio planning - Jammu Links News
Is Stoke Therapeutics Inc. a growth stock or a value stockRemarkable growth - Jammu Links News
Is it the right time to buy Stoke Therapeutics Inc. stockMaximize returns with expert trading insights - Jammu Links News
How many analysts rate Stoke Therapeutics Inc. as a “Buy”Invest confidently with data-driven strategies - Jammu Links News
What analysts say about Stoke Therapeutics Inc. stockRapid return acceleration - Jammu Links News
Does Stoke Therapeutics Inc. stock perform well during market downturnsAchieve breakthrough results with expert guidance - Jammu Links News
How strong is Stoke Therapeutics Inc. company’s balance sheetMaximize your portfolio’s growth potential - Jammu Links News
How volatile is Stoke Therapeutics Inc. stock compared to the marketUnlock expert insights for smarter investing - Jammu Links News
How does Stoke Therapeutics Inc. compare to its industry peersRapid wealth accumulation - Jammu Links News
What catalysts could drive Stoke Therapeutics Inc. stock higher in 2025Double or triple returns - Jammu Links News
What drives Stoke Therapeutics Inc. stock priceDiscover investment plans that deliver results - Jammu Links News
What makes Stoke Therapeutics Inc. stock price move sharplyUnlock hidden market opportunities today - Jammu Links News
When is Stoke Therapeutics Inc. stock expected to show significant growthGet expert insights on market-moving stocks - Jammu Links News
What are Stoke Therapeutics Inc. company’s key revenue driversExpert Picks Target Finder For Consistent Profits - Jammu Links News
Analysts Estimate Stoke Therapeutics, Inc. (STOK) to Report a Decline in Earnings: What to Look Out for - MSN
Real time breakdown of Stoke Therapeutics Inc. stock performanceAI Trading Suggestions With Accuracy Focus Released - metal.it
Bullish Candlestick Pattern Forms in Stoke Therapeutics Inc.Sector Based Breakout Stock Forecast Issued - metal.it
Multi asset correlation models including Stoke Therapeutics Inc.Entry Zone Forecast for Momentum Trading - Newser
Price Channel Expanding on Stoke Therapeutics Inc.’s ChartTrade Setups With AI Powered Filters Published - metal.it
What moving averages say about Stoke Therapeutics Inc.Low Risk High Confidence Watchlist Builder - Newser
Published on: 2025-07-29 08:55:21 - metal.it
Combining machine learning predictions for Stoke Therapeutics Inc. Breakout Watcher with Entry and Exit Alerts - Newser
Is Stoke Therapeutics Inc. Stock a Good Fit for Conservative Investors Technical Screener for High Growth Stocks - metal.it
What are analysts’ price targets for Stoke Therapeutics Inc. in the next 12 monthsDiscover market opportunities others miss - Jammu Links News
How does Stoke Therapeutics Inc. generate profit in a changing economyInvest smarter with actionable market insights - Jammu Links News
Published on: 2025-07-27 18:16:44 - Jammu Links News
Stoke Therapeutics Inc (STOK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):